Jacques Dantal

10.5k total citations · 2 hit papers
147 papers, 5.8k citations indexed

About

Jacques Dantal is a scholar working on Transplantation, Surgery and Nephrology. According to data from OpenAlex, Jacques Dantal has authored 147 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Transplantation, 51 papers in Surgery and 38 papers in Nephrology. Recurrent topics in Jacques Dantal's work include Renal Transplantation Outcomes and Treatments (67 papers), Renal Diseases and Glomerulopathies (35 papers) and Organ Transplantation Techniques and Outcomes (31 papers). Jacques Dantal is often cited by papers focused on Renal Transplantation Outcomes and Treatments (67 papers), Renal Diseases and Glomerulopathies (35 papers) and Organ Transplantation Techniques and Outcomes (31 papers). Jacques Dantal collaborates with scholars based in France, Germany and United States. Jacques Dantal's co-authors include Jean‐Paul Soulillou, Diego Cantarovich, Gilles Blancho, Maryvonne Hourmant, Magali Giral, Brigitte Dréno, Jean Paul Soulillou, Georges Karam, Erich Pohanka and Pascal Daguin and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Jacques Dantal

141 papers receiving 5.7k citations

Hit Papers

Effect of long-term immunosuppression in kidney-graft rec... 1998 2026 2007 2016 1998 2003 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens
    1998 567 citations Jacques Dantal, Maryvonne Hourmant et al. profile →
  2. NEW-ONSET DIABETES AFTER TRANSPLANTATION: 2003 INTERNATIONAL CONSENSUS GUIDELINES1
    2003 557 citations Jacques Dantal, Christophe Legendre et al. Transplantation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacques Dantal France 39 2.6k 1.8k 1.3k 1.3k 1.2k 147 5.8k
Maryvonne Hourmant France 34 2.0k 0.8× 1.2k 0.7× 1.1k 0.8× 746 0.6× 791 0.6× 134 4.8k
Bernd Döhler Germany 37 3.4k 1.3× 2.2k 1.2× 600 0.5× 1.2k 0.9× 912 0.7× 103 5.2k
Heinz Regele Austria 45 3.4k 1.3× 2.4k 1.4× 1.7k 1.3× 911 0.7× 689 0.6× 188 6.9k
Kazunari Tanabe Japan 40 1.6k 0.6× 1.9k 1.1× 872 0.7× 1.1k 0.9× 448 0.4× 376 5.6k
Gaetano Ciancio United States 44 3.0k 1.1× 3.2k 1.8× 872 0.7× 585 0.5× 785 0.6× 363 7.2k
Magali Giral France 44 4.0k 1.5× 2.4k 1.3× 565 0.4× 713 0.6× 1.3k 1.0× 187 6.4k
Ashley Vo United States 40 3.6k 1.4× 2.0k 1.1× 1.2k 0.9× 592 0.5× 759 0.6× 129 5.7k
Vincent Audard France 35 747 0.3× 937 0.5× 1.3k 1.0× 1.2k 0.9× 482 0.4× 182 4.8k
K. Salmela Finland 41 1.9k 0.7× 3.2k 1.8× 564 0.4× 541 0.4× 866 0.7× 189 5.6k
Denis Glotz France 50 6.0k 2.3× 3.8k 2.1× 2.2k 1.7× 740 0.6× 1.2k 1.0× 206 9.0k

Countries citing papers authored by Jacques Dantal

Since Specialization
Citations

This map shows the geographic impact of Jacques Dantal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Dantal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Dantal more than expected).

Fields of papers citing papers by Jacques Dantal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Dantal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Dantal. The network helps show where Jacques Dantal may publish in the future.

Co-authorship network of co-authors of Jacques Dantal

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Dantal. A scholar is included among the top collaborators of Jacques Dantal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Dantal. Jacques Dantal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Savoye, Émilie, Laurent Martin‐Lefèvre, Jacques Dantal, et al.. (2024). Risk Factors for Adverse Outcomes in Kidney Transplants From Donors After Circulatory Death With Normothermic Regional Perfusion: A Systematic Analysis. Transplantation. 108(12). e417–e427.
2.
Masset, Christophe, Richard Danger, Nicolas Degauque, et al.. (2024). Blood Gene Signature as a Biomarker for Subclinical Kidney Allograft Rejection: Where Are We?. Transplantation. 109(2). 249–258. 3 indexed citations
3.
Meur, Yannick Le, Emmanuel Nowak, Benoı̂t Barrou, et al.. (2023). Evaluation of the efficacy of HEMO2life®, a marine OXYgen carrier for Organ Preservation (OxyOp2) in renal transplantation: study protocol for a multicenter randomized trial. Trials. 24(1). 302–302. 5 indexed citations
4.
Masset, Christophe, Paul Le Turnier, Céline Bressollette‐Bodin, et al.. (2022). Virus-Associated Nephropathies: A Narrative Review. International Journal of Molecular Sciences. 23(19). 12014–12014. 10 indexed citations
5.
Choukroun, Gabriel, Jacques Dantal, Lionel Couzi, et al.. (2022). Prévalence de la carence martiale dans une population de patients insuffisants rénaux chroniques non dialysés : étude nationale multicentrique observationnelle CARENFER. Néphrologie & Thérapeutique. 18(3). 195–201. 3 indexed citations
6.
Kerleau, Clarisse, et al.. (2020). Association between Use of Hydrochlorothiazide and Risk of Keratinocyte Cancers in Kidney Transplant Recipients. Clinical Journal of the American Society of Nephrology. 15(12). 1804–1813. 11 indexed citations
7.
Boucquemont, Julie, Yohann Foucher, Christophe Masset, et al.. (2020). Induction therapy in kidney transplant recipients: Description of the practices according to the calendar period from the French multicentric DIVAT cohort. PLoS ONE. 15(10). e0240929–e0240929. 11 indexed citations
8.
Martı́n, Carmen San, Jan Nico Bouwes Bavinck, Évelyne Decullier, et al.. (2016). KIDNEY RETRANSPLANTATION IN PATIENTS HAVING PRESENTED AT LEAST ONE SQUAMOUS CELL CARCINOMA DURING A PREVIOUS TRANSPLANTATION PERIOD EXPOSES TO A HIGH RISK OF AGGRESSIVE SKIN SQUAMOUS CELL CARCINOMA. Transplant International. 29. 7–7. 1 indexed citations
9.
Euvrard, Sylvie, Emmanuel Morélon, Lionel Rostaing, et al.. (2012). Sirolimus and Secondary Skin-Cancer Prevention in Kidney Transplantation. New England Journal of Medicine. 367(4). 329–339. 380 indexed citations
10.
Maillard, Olivier, Stéphane Corvec, Jacques Dantal, et al.. (2010). Emergence of High Ampicillin-Resistant Enterococcus faecium Isolates in a Kidney Transplant Ward: Role of Antibiotic Pressure and Cross Transmission. Microbial Drug Resistance. 16(2). 123–128. 4 indexed citations
11.
Ashton‐Chess, Joanna, Hoa Le, Vojislav Jovanović, et al.. (2010). Immunoproteasome beta subunit 10 is increased in chronic antibody-mediated rejection. Kidney International. 77(10). 880–890. 22 indexed citations
12.
Dantal, Jacques & Erich Pohanka. (2007). Malignancies in renal transplantation: an unmet medical need. Nephrology Dialysis Transplantation. 22(Supplement 1). i4–i10. 96 indexed citations
13.
Vı́tko, Š, Raimund Margreiter, Willem Weimar, et al.. (2005). Three‐Year Efficacy and Safety Results from a Study of Everolimus Versus Mycophenolate Mofetil in de novo Renal Transplant Patients. American Journal of Transplantation. 5(10). 2521–2530. 176 indexed citations
14.
Berre, Ludmilla Le, et al.. (2005). Renal macrophage activation and Th2 polarization precedes the development of nephrotic syndrome in Buffalo/Mna rats. Kidney International. 68(5). 2079–2090. 85 indexed citations
15.
Hourmant, Maryvonne, Anne Cesbron‐Gautier, Paul I. Terasaki, et al.. (2005). Frequency and Clinical Implications of Development of Donor-Specific and Non–Donor-Specific HLA Antibodies after Kidney Transplantation. Journal of the American Society of Nephrology. 16(9). 2804–2812. 232 indexed citations
16.
Berre, Ludmilla Le, Yann Godfrin, E. Günther, et al.. (2002). Extrarenal effects on the pathogenesis and relapse of idiopathic nephrotic syndrome in Buffalo/Mna rats. Journal of Clinical Investigation. 109(4). 491–498. 4 indexed citations
17.
Berre, Ludmilla Le, Yann Godfrin, E. Günther, et al.. (2002). Extrarenal effects on the pathogenesis and relapse of idiopathic nephrotic syndrome in Buffalo/Mna rats. Journal of Clinical Investigation. 109(4). 491–498. 43 indexed citations
18.
19.
Giral, Magali, María Cristina Cuturi, Jean‐Michel Nguyen, et al.. (1997). DECREASED CYTOTOXIC ACTIVITY OF NATURAL KILLER CELLS IN KIDNEY ALLOGRAFT RECIPIENTS TREATED WITH HUMAN HLA-DERIVED PEPTIDE. Transplantation. 63(7). 1004–1011. 20 indexed citations
20.
Mauff, Brigitte Le, Maryvonne Hourmant, Jean‐Philippe Rougier, et al.. (1991). EFFECT OF ANTI-LFA1 (CD11a) MONOCLONAL ANTIBODIES IN ACUTE REJECTION IN HUMAN KIDNEY TRANSPLANTATION. Transplantation. 52(2). 291–295. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maryvonne Hourmant Breakdown of academic impact, for papers by Bernd Döhler Breakdown of academic impact, for papers by Heinz Regele Breakdown of academic impact, for papers by Kazunari Tanabe Breakdown of academic impact, for papers by Gaetano Ciancio Breakdown of academic impact, for papers by Magali Giral Breakdown of academic impact, for papers by Ashley Vo Breakdown of academic impact, for papers by Vincent Audard Breakdown of academic impact, for papers by K. Salmela Breakdown of academic impact, for papers by Denis Glotz
Rankless by CCL
2026